Abridge, a Pittsburgh, PA-based startup that specializes in generative AI for clinical documentation, secured $150 million in Series C funding.

The startup also announced a new enterprise agreement with the Yale New Haven Health System to enhance clinical documentation for thousands of clinicians.   

SaaS Investors 

The round was led by Lightspeed Venture Partners and Redpoint Ventures, with support from IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and CVS Health Ventures.  

Founded in 2000, Lightspeed Venture Partners is a venture capital firm based in Menlo Park, California. The firm has regional offices in Israel, India, China, Southeast Asia, and Europe. The firm seeks to invest in the enterprise, health, fintech, and consumer sectors.  

Redpoint Ventures is a venture capital firm that seeks to invest in companies operating in the application, blockchain, consumer, financial technology, healthcare, and infrastructure sectors. Founded in 1999 and is based in Woodside, California.   

Abridge Use of Funds 

With the fresh funds, the company will continue to push boldly into fundamental research, developing bedrock foundation models that draw upon vast troves of multimodal healthcare data.  

About Abridge 

Founded in 2018 with the mission of powering deeper understanding in healthcare, Abridge is a healthcare startup that structures and summarizes medical conversations for doctors and patients. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real time with deep EMR integrations.  

Funding Details

Company: Abridge Al, Inc.  

Raised: $150.0M     

Round: Series C  

Funding Month: February 2024                      

Lead Investors: Lightspeed Venture Partners and Redpoint Ventures   

Additional Investors: IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and CVS Health Ventures  

Company Website: https://www.abridge.com/   

Software Category: Healthcare  

Source: https://www.abridge.com/press-release/series-c-150